Compound aluminum sulfate

复方硫酸铝

Report date: 2023/01/08 19:05:55

Base Information

Drug NameCompound aluminum sulfate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPeople'S Liberation Army General Hospital Military ServiceChangchun Baike Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPla General HospitalJilin Huakang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A